|
Journal description
All volumes of the corresponding journal
All issues of the corresponding volume
All articles of the corresponding issues
6 results found
| no | title | author | magazine | year | volume | issue | page(s) | type |
| 1 | After the LEADER trial and SUSTAIN-6, how do we explain the cardiovascular benefits of some GLP-1 receptor agonists? |
Vergès, B. |
2017 |
43 | S1 |
p. 2S3-2S12 nvt p. |
article |
|
| 2 | GLP-1 receptor agonist confer target organ protection in type 2 diabetes |
Bonnet, Fabrice |
2017 |
43 | S1 |
p. 2S1-2S2 nvt p. |
article |
|
| 3 | GLP-1 receptor agonists and heart failure in diabetes |
Scheen, André J. |
2017 |
43 | S1 |
p. 2S13-2S19 nvt p. |
article |
|
| 4 | GLP-1 receptor agonists in NAFLD |
Petit, J.-M. |
2017 |
43 | S1 |
p. 2S28-2S33 nvt p. |
article |
|
| 5 | The potential and pitfalls of GLP-1 receptor agonists for renal protection in type 2 diabetes |
Thomas, Merlin C. |
2017 |
43 | S1 |
p. 2S20-2S27 nvt p. |
article |
|
| 6 | Use of GLP-1 receptor agonists for type 2 diabetes treatment intensification after basal insulin failure |
Joubert, M. |
2017 |
43 | S1 |
p. 2S34-2S38 nvt p. |
article |
6 results found